Scancell Holdings PLC. (SCNLF)

[Blue Fire]

SCANCELL TO POST SUCCESSFUL CANCER VACCINE TRIAL RESULTS

Britain's Sunday Times newspaper gave investors the 'head's up' on Scancell's cancer vaccine trial success today:


Boffins in skin cancer success

A BIOTECH business developing a treatment for melanoma, a deadly form of skin cancer, is set to publish data that shows it appears to work.

The success of the trials on about 20 patients is likely to prompt Scancell, which is listed on AIM, to try to raise funds from a big pharma company to carry out tests with a far larger number of people. It does not have the infrastructure to run big tests on its own.

Such a deal could see the company license its technology to a partner or sell itself outright.

The British company’s treatment tackles cancer cells using the body’s immune system. Several of the world’s biggest drugs developers, including Roche and Merck, are interested in this type of approach to treating cancer.


Read the complete article here:
Boffins in skin cancer success